Precise dosing, more comfort, better outcomes.
We see a better way.
Kedalion Therapeutics is focused on revolutionizing the delivery of topical ocular medicine to significantly increase patient comfort and ease of use. Kedalion’s AcuStreamTM technology is being developed for delivery of topical drugs to the eye in a precise and accurate manner that will enable comparable therapy with an 80% reduction in dose relative to standard drops. The potential for reduced side effects and increased patient comfort is intended to transform the concept of simplicity, convenience and adherence in self-administered care for leading ocular diseases.
Studies show…
More than
90% of patients
dose improperly
24% of
eye drop bottles
are contaminated 1
30% of patients
who think they have good technique actually
miss the eye 2
Introducing AcuStream™
A Novel Delivery System to Improve Patient Outcomes
Kedalion’s AcuStream technology is being developed to revolutionize the delivery of topical eye medications with a goal of achieving better patient experiences and outcomes.
1. B. Teucher, J. Wagner, et al. Microbial contamination of glaucoma eye drops used by patients compared with ocular medications used in the hospital
2. A.J. Winfield, D. Jessiman et al. A study of the causes of non-compliance by patients prescribed eyedrops.. Br.J.. Ophthal.1990 Aug;74(8):477-480; Online Medicine (Baltimore), 2015; 94(8):e583